Brian McBride, Pharm.D., a research fellow in the Division of Clinical Pharmacology, was selected by the American Society of Health Systems-Pharmacists to receive the 2005 Drug Therapy Research Award.
The national award, which recognizes an outstanding contribution to the biomedical literature involving drug efficacy and safety in humans, was presented to McBride at the ASHP Midyear Clinical Meeting in Las Vegas on Dec. 5.
The research paper was published in the Journal of the American Medical Association (JAMA). The study showed that a single dose of a dietary weight loss supplement containing ephedra and caffeine could cause abnormal heartbeats. This research contributed to the Food and Drug Administration ban of ephedra-containing dietary supplements.
As a fellow in the laboratory of Dan M. Roden, M.D., McBride is currently investigating patient variability in the clinical response to antiarrhythmic medications.